Linee guida
La prima infezione urinaria febbrile in bambini di etą compresa tra 2 mesi e 3 anni
Updated Italian recommendations for the diagnosis, treatment and follow-up of the first febrile urinary tract infection in children AGED between 2 months and 3 years
Gruppo di lavoro sulle infezioni delle vie urinarie della Societą Italiana di Nefrologia Pediatrica (SINePe)
Ottobre 2020 - pagg. 495 -504 | DOI: 10.53126/MEB39495
Abstract
The aim was to update the recommendations for the diagnosis, treatment and follow-up of the first febrile urinary tract infection in young children, which were first published in 2012 and endorsed by the Italian Society of Paediatric Nephrology. The Italian recommendations were revised on the basis of a review of the literature published from 2012 to October 2018. An ad hoc evaluation of the risk factors, which were published in the previous recommendations, was carried out to identify children with high-grade vesicoureteral reflux or renal scarring. When evidence was not available, the working group held extensive discussions during various meetings and through email exchanges. Four major modifications have been introduced. The method for collecting urine for culture and its interpretation has been re-evaluated. The algorithm that guides clinical decisions to proceed with voiding cystourethrography has been reformulated. The suggested antibiotics have been revised and further restrictions of the use of antibiotic prophylaxis have been recommended. These updated recommendations have now been endorsed by the Italian Society of Paediatric Nephrology and the Italian Society for Paediatric Infectivology. They can also be used to compare other available recommendations, as a worldwide consensus in this area is still lacking.
Parole chiave
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Gruppo di lavoro della Societą Italiana di Nefrologia Pediatrica (SINP) (A cura di). Le infezioni febbrili delle vie urinarie. Medico e Bambino 2009;28:359-70.
2. Alberici I, La Manna A, Pennesi M, et al. First urinary tract infections in children: the role of the risk factors proposed by the Italian recommendations. Acta Pędiatr 2019: 108:544-50.
3. Ebell MH, Siwek J, Weiss BD, et al. Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004;69:549-57.
4. National Institute for Health and Clinical Excellence (NICE). Clinical Guideline. Urinary tract infection under 16s: diagnosis and management. Published August 2007. Last updated: October 2018. Avalaible at: https://www.nice.org.uk/guidance/cg54.
5. AAP Subcommittee on Urinary Tract Infection. Reaffirmation of AAP Clinical Practice Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children 2-24 Months of Age. Pediatrics 2016;138:e20163026.
6. Hernandez-Bou S, Trenchs V, Alarcon M, Luaces C. Afebrile very young infants with urinary tract infection and the risk for bacteremia. Pediatr Infect Dis J 2014;33:244-7.
7. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics 2001;108:311-6.
8. Gauthier M, Gouin S, Phan V, Gravel J. Association of malodorous urine with urinary tract infection in children aged 1 to 36 months. Pediatrics 2012;129:885-90.
9. Williams GJ, Macaskill P, Chan SF, Turner RMN, Hodson E, Graig JC. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis 2010;10:240-50.
10. Roberts KB, Wald ER. The diagnosis of UTI: Colony Count Criteria revisited. Pediatrics 2018;141:e20173239.
11. Mc Taggart S, Danchin M, Ditchfield M, Hewitt I, Kausman J, Kennedy S, et al. KHA-CARI Guideline. Diagnosis and treatment of urinary tract infection in children. Nephrology 2015;20:55-60.
12. Bajaj L, Bothner J. Urine collection techniques in infants and children with suspected urinary tract infection. Uptodate 2018 (literature review current through: feb 2019. Topic last updated: dec 04, 2018. Available at: www.uptodate.com/store).
13. Baron EJ, Miller JM, Weinstein MP, et al. Executive Summary: a Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis 2013; 57:485-8.
14 Kaufman J, Fitzpatrick P, Tosif S, et al. The QuickWee trial: protocol for a randomised controlled trial of gentle soprapubic cutaneous stimulation to hasten non-invasive urine collection from infants. BMJ Open 2016; 6:e011357.
15. Kaufman J, Tosif S, Fitzpatrick P, et al. Quick-Wee: a novel non- invasive urine collection method. Emerg Med J 2017;34 63-4.
16. Tran A, Fortier C, Giovannini-Chami L, et al. Evaluation of the Bladder Stimulation Technique to Collect Midstream urine in Infants in a Pediatric Emergency Department. Plos One 2016;11:e0152598.
17. Herreros ML, Tagarro A, Garcia-Pose A, Sanchez A, Cańete A, Gili P. Accuracy of a new clean-catch technique for diagnosis of urinary tract infection in infants younger than 90 days of age. Pediatr Child Health 2015;20:e30-32.
18. Labrosse M, Levy A, Autmizguine J, Grave J. Evaluation of a New Strategy for Clean Catch urine in Infants. Pediatrics 2016;138: e2 0160573
19. Robinson JL, Finlay JC, Lang ME, Bortolussi R; Canadian Pediatric Society. Infectious Disease and Immunization Committee, Community Paediatrics Committee. Urinary tract infections in Infants and Children: Diagnosis and Management. Paediatr Child Health 2014;19:315-9. Reaffirmed: Jan 30 2017.
20. Simões e Silva AC, Oliveira EA. Update on the approach of urinary tract infection in childhood. J Pediatr (Rio J) 2015;91:S2-10.
21. LaRocco MT, Franek J, Leibach EK, et al. Effectiveness of Preanalytic Practices on Contamination and diagnostic Accuracy of Urinary Cultures: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis. Clin Microbiol Rev 2016;29:105-47.
22. Lavelle JM, Blackstone MM, Funari MK, et al. Two-Step Process for ED UTI Screening in Febrile Young Children: Reducing Catheterization Rates. Pediatrics 2016;138: e20153023.
23. Whiting P, Westwood M, Bojke L, et al. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technol Assess 2006;10:1-154.
24 Shaikh N, Morone NE, Lopez J, et al. Does this child have a urinary tract infection? Jama 2007; 298:2895-904.
25. Al-Orifi F, McGillivray D, Tange S, Kramer MS. Urine culture from bag in young children: are the risks too high? J Pediatr 2000;137:221-6.
26. Etoubleau C, Reveret M, Brouet D, et al. Moving from bag to catheter for urine collection in non-toilet-trained children suspected of having urinary tract infection: a paired comparison of urine cultures. J Pediatr 2009; 154:803-6.
27. Mori R, Yonemoto N, Fitzgerald A, Tullus K, Verrier-Jones K, Lakhanpaul M. Diagnostic performance of urine disptick testing in children with suspected UTI: a systematic review of relationship with age and comparison with microscopy. Acta Pędiatr 2010;99:581-4.
28. Glissmayer EW, Korgenski EK, Wilkes J, et al. Dipstick screening for urinary tract infection in febrile infants. Pediatrics 2014;133: e1121-1127.
29. Kanegaye JT, Jacob JM, Malikli D. Automated urinalysis and urine dipstick in the emergency evaluation of young febrile children. Pediatrics 2014;134:523-9.
30. Schroeder AR, Chang PW, Shen MW, Biondi EA, Greenhow TL. Diagnostic Accuracy of The Urinalysis for Urinary Tract Infection in Infants < 3 months of age. Pediatrics 2015;135:965-71.
31. Velasco R, Benito H, Mozun R, et al. Using a urine dipstick to identify a positive urine culture in young febrile infants is as effective as in older patients. Acta Paediatr 2015;104:e39-44.
32. Shaikh N, Borrel JL, Evrol J, Leeflang MM. Procalcitonin, C-reactive protein and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children. Cochrane Database Syst Rev 2015;1: CD009185.
33. National Institute of Health and Clinical Excellence. Urinary tract infection in children: diagnosis, treatment and long-term management. NICE Clinical Guideline, August 2007.
34. Morello W, La Scola C, Alberici I, Montini G. Acute pyelonephritis in children. Pediatr Nephrol 2016;3:1253-65.
35. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med 2011;365:239-50.
36. Doganis D, Sinaniotis K. Early antibiotic treatment of pyelonephritis in children is still mandatory. Pediatrics 2009;123:e173-4.
37. Karavanaki KA, Soldatou A, Koufadaki AM, Tsentidis C, Haliotis FA, Stefanidis CJ. Delayed treatment of the first febrile urinary tract infection in early childhood increased the risk of renal scarring. Acta Paediatr 2017;106:149-54.
38. Hewitt IK, Zucchetta P, Rigon L, et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics 2008;122:486-90.
39. Coulthard MG, Verber I, Jani JC, et al. Can prompt treatment of childhood UTI prevent kidney scarring? Pediatr Nephrol 2009; 24:2059-63.
40. Oh MM, Kim JW, Park MG, Kim JJ, Yoo KH, Moon DG. The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI. Eur J Pediatr 2012;171:565-70.
41. Iacobelli S, Bonsante F, Guignard JP. Infections urinaires en pediatrie. Arch Pediatr 2009;16:1073-9.
42. Montini G, Toffolo A, Zucchetta P, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ 2007;335:386.
43. Bocquet N, Sergent Alaoui A, Jais J-P, et al. Randomized trial of oral versus sequential IV/oral antibiotic for acute pyelonephritis in children. Pediatrics 2012;129:e269-75.
44. Arshad M, Seed PC. Urinary tract infections in the infant. Clin Perinatol 2015;42:17- 28.
45. Stein R, Dogan HS, Hoebeke P, et al. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol 2015;67:546-58.
46. American Academy of Pediatrics. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595-610.
47. Masson P, Matheson S, Webster AC, Craig JC. Meta-analyses in prevention and treatment of urinary tract infections. Infect Dis Clin North Am 2009;23:355-85.
48. Schmidt B, Copp HL. Work-up of Pediatric Urinary Tract Infection. Urol Clin North Am 2015; 42: 519-26.
49. Traisman ES. Clinical Management of Urinary Tract Infections. Pediatr Ann 2016; 45:e108-11. Review.
50. Mårild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr 1998;87:549-52.
51. OBrien K, Stanton N, Edwards A, Hood K, Butler CC. Prevalence of urinary tract infection (UTI) in sequential acutely unwell children presenting in primary care: exploratory study. Scand J Prim Health Care 2011; 29:19-22.
52. Kanellopoulos TA, Salakos C, Spiliopoulou I, Ellina A, Nikolakopoulou NM, Papanastasiou DA. First urinary tract infection in neonates, infants and young children: a comparative study. Pediatr Nephrol 2006;21: 1131-7.
53. Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev 2005;18:417-22.
54. Ismaili K, Lolin K, Damry N, Alexander M, Lepage P, Hall M. Febrile urinary tract infections in 0-to 3-month-old infants: a prospective follow-up study. J Pediatr 2011;158: 91-4.
55. Saadeh SA, Mattoo TK. Managing urinary tract infections. Pediatr Nephrol 2011; 26:1967-76.
56. Tamma PD, Sklansky DJ, Palazzi DL, Swami SK, Milstone AM. Antibiotic susceptibility of common pediatric uropathogens in the United States. Clin Infect Dis 2014;59: 750-2.
57. Mazzone C, Laneve M, Resta F. Indagine epidemiologica locale delle infezioni delle vie urinarie in etą pediatrica: eziologia e profilo di sensibilitą agli antibiotici. RIMeL/IJLaM 2008;4:280-4.
58. Giardino S, Bandettini R, Perotti M, et al.
Gram-negative urinary tract infections and increasing isolation of ESBL-producing or ceftazidime-resistant strains in children: results from a single-centre survey. Infez Med 2013; 21:29-33.
59. Calitri C, Scolfaro C, Colombo S, et al. Extended-Spectrum Beta Lactamase-producing Enterobacteriaceae among the pediatric population:who is at risk and why? Results from a single-centre prospective study. Infez Med 2016;24:318-25.
60. Calzi A, Grignolo S, Caviglia I, et al. Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children. Eur J Pediatr 2016;175:1219-25.
61. Caracciolo A, Bettinelli A, Bonato C, et al. Antimicrobial resistance among Escherichia coli that cause childhood community-acquired urinary tract infections in Northern Italy. Ital J Pediatr 2011;37:3.
62. De Luca M, Doną D, Montagnani C, et al. Antibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project. PLoS ONE 2016; 11:e0154662.
63. Malloy AM, Campos JM. Extended-spectrum beta-lactamases: a brief clinical update. Pediatr Infect Dis 2011;30:1092-3.
64. Nicolini G, Sperotto F, Esposito S. Combating the rise of antibiotic resistance in children. Minerva Pediatr 2014;66:31-9.
65. Jackson EC. Urinary tract infections in children: knowledge updates and a salute to the future. Pediatr Rev 2015;36:153-64.
66. Mårild S, Jodal U, Sandberg T. Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children. Pediatr Nephrol 2009;24: 521-6.
67. Dinleyici EC, Bor O, Kebapci M, Aydogdu SD. Ceftriaxone-associated cholelithiasis: 30 min drip infusion versus bolus injection. Pediatr Int 2010;52:890.
68. Abel zur Wiesch P, Clarelli F, Cohen T. Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies. PLoS Comput Biol 2017;13:e1005321.
69. Opatowski L, Mandel J, Varon E, Boėlle PY, Temime L,Guillemot L. Antibiotic Dose Impact on Resistance Selection in the Community: a Mathematical Model of β-Lactams and Streptococcus pneumoniae Dynamics. Antimicrob Agents Chemother 2010;54:2330-7.
70. Han SB, Lee SC, Lee SY, Jeong DC, Kang JH. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. BMC Infect Dis 2015;15:414.
71. Poey N, Madhi F, Biscardi S, Béchet S, Cohen R. Aminoglycosides Monotherapy as First-Line Treatment for Febrile Urinary Tract Infection in Children. Pediatr Infect Dis J 2017;36:1104-7.
72. Duffy MA, Hernandez-Santiago V, Orange G, Davey PG, Guthrie B. Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis. Br J Gen Pract 2013;63: e238-43.
73. Koyle MA, Barqawi A, Wild J, Passamaneck M, Furness PD 3rd. Pediatric urinary tract infections: the role of fluoroquinolones. Pediatr Infect Dis J 2003;22:1133-7.
74. European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. EMA/795349/ 2018
75. Gökēe İ, Ēiēek N, Güven S, et al. Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy. Balkan Med J 2017;34:432-5.
76. Benador D, Neuhaus TJ, Papazyan JP, et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child 2001;84:241-6.
77. Beetz R, Bachmann H, Gatermann S, et al. Urinary tract infections in infants and children - a consensus on diagnostic, therapy and prophylaxis. Urologe A 2007;46:112, 114-8, 120-3.
78. Brady PW, Conway PH, Goudie A. Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections. Pediatrics 2010;126:196-203.
79. Huang YY, Chen MJ, Chiu NT, Chou HH, Lin KY, Chiou YY. Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring. Pediatrics 2011; 128:e496-e504.
80. Lee HY, Soh BH, Hong CH, Kim MJ, Han SW. The efficacy of ultrasound and dimercaptosuccinic acid scan in predicting vesicoureteral reflux in children below the age of 2 years with their first febrile urinary tract infection. Pediatr Nephrol 2009;24:2009-13.
81. Gordon ZN, McLeod DJ, Becknell B, Bates DG, Alpert SA. Uroepithelial thickening on sonography improves detection of vesicoureteral reflux in children with first febrile urinary tract infection. J Urol 2015;194:1074-9.
82. Pauchard JY, Chehade H, Kies CZ, Girardin E, Cachat F, Gehri M. Avoidance of voiding cystourethrography in infants younger than 3 months with Escherichia coli urinary tract infection and normal renal ultrasound. Arch Dis Child 2017;102:804-8.
83. Frimberger D, Mercado-Deane MG; AAP Section on Urology; AAP Section on Radiology. Establishing a standard protocol for the voiding cystourethrography. Pediatrics 2016; 138:e20162590.
84. Darge K. Voiding urosonography with US contrast agents for the diagnosis of vesicoureteric reflux in children. II. Comparison with radiological examinations. Pediatr Radiol 2008;38:54-63.
85. Mane N, Sharma A, Patil A, Gadekar C, Andankar M, Pathak H. Comparison of contrast-enhanced voiding urosonography with voiding cystourethrography in pediatric vesicoureteral reflux. Turk J Urol 2018;44:261-7.
86. Papadopoulou F, Ntoulia A, Siomou E, Darge K. Contrast-enhanced voiding urosonography with intravesical administration of a second-generation ultrasound contrast agent for diagnosis of vesicoureteral reflux: prospective evaluation of contrast safety in 1,010 children. Pediatr Radiol 2014;44:719-28.
87. Johnson EK, Malhotra NR, Shannon R, et al. Urinary tract infection after voiding cystourethrogram. J Pediatr Urol 2017;13:384.
88. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010;126:1084-91.
89. Shaikh N, Craig JC, Rovers MM, et al. Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr 2014;168: 893-900.
90. Keren R, Shaikh N, Pohl H, et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics 2015;136:e13-21.
91. Shaikh N, Hoberman A, Keren R, et al. Recurrent urinary tract infection in children with bladder and bowel dysfunction. Pediatrics 2016;137:e20152982.
92. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006;117:626-32.
93. Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low-grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008; 179:674-9.
94. Montini G, Rigon L, Zucchetta P, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 2008; 122:1064-71.
95. Pennesi M, Travan L, Peratoner L, et al. North East Italy Prophylaxis in VUR study group. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 2008;121: e1489-94.
96. Craig JC, Simpson JM, Williams GJ, et al. Prevention of Recurrent Urinary Tract Infection in Children with Vesicoureteric Reflux and Normal Renal Tracts (PRIVENT) Investigators. N Engl J Med 2009;361:1748-59.
97. Dai B, Liu Y, Jia J, Mei C. Long-term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta-analysis. Arch Dis Child 2010;95:499-508.
98. Wang HH, Gbadegesin RA, Foreman JW, et al. Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis. J Urol 2015;193: 963-9.
99. de Bessa J Jr, de Carvalho Mrad FC, Mendes EF, et al. Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux: a meta-analysis of randomized, controlled trials comparing dilated to nondilated vesicoureteral reflux. J Urol 2015;193(5 Suppl):1772-7.
100. The RIVUR Trial Investigators. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 2014;370:2367-76.
101. Selekman RE, Shapiro DJ, Boscardin J, et al. Uropathogen Resistance and Antibiotic Prophylaxis: A Meta-analysis. Pediatrics 2018;142:e20180119.
102. Hewitt IK, Pennesi M, Morello W, Ronfani L, Montini G. Antibiotic Prophylaxis for Urinary Tract Infection-Related Renal Scarring: A Systematic Review. Pediatrics 2017; 139:e20163145.
103. Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother 2015;70:2456-64.
104. Tewary K, Narchi H. Recurrent urinary tract infections in children: Preventive interventions other than prophylactic antibiotics. World J Methodol 2015;5:13-9.
105. Salo J, Uhari M, Helminen M, Korppi M, et al. Cranberry Juice for the Prevention of Recurrences of Urinary Tract Infections in Children: A Randomized Placebo-Controlled Trial. Clin Infect Dis 2012;54:340-6.
106. Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in children and adults. Cochrane Database of Systematic Reviews 2015;12: CD008772.
107. Toffolo A, Ammenti A, Montini G. Long-term clinical consequences of urinary tract infections during childhood: a review. Acta Paediatr 2012;101:1018-31.
108. Ammenti A, Alberici I, Brugnara M, et al. Updated Italian recommendations for the diagnosis, treatment and follow up of the first febrile urinary tract infection in young children. Acta Paediatr 2020;109(2): 236-47.
Corrispondenza: giovanni.montini@unimi.it